Afuco™ Anti-Human TNFSF14 ADCC Therapeutic Antibody (SAR252067), ADCC Enhanced
Anti-TNFSF14 ADCC Enhanced Antibody (SAR252067) is an ADCC enhanced antibody produced by our Afuco™ platform. SAR 252067 is an anti-LIGHT fully human monoclonal antibody that is being developed for the treatment of ulcerative colitis and crohn's disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-615CL |
| Pricing | Inquiry |
| Host | Human |
| Target | TNFSF14 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FuncS |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |